Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-27
2005-12-27
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S498000
Reexamination Certificate
active
06979683
ABSTRACT:
The invention relates to benzimidazole derivatives of general formula (I)in whichX represents a nitrogen atom or a carbon atom;and when X represents a nitrogen atomR3 represents in particular a hydrogen atom or a (C1-C4)alkyl group,R4 represents in particular a hydrogen atom; a (C1-C6)alkyl; (C3-C7)cycloalkyl; 4-piperidyl; —(CH2)p—NR5R6; —(CH2)p—CONR5R6; —CO—(CH2)p—NR5R6; —(CH2)p-phenyl; —(CH2)p-morpholinyl; —(CH2)p-pyrrolidinyl; —(CH2)p-tetrahydroisoquinoline; —(CH2)p-heteroaryl; heteroarylcarbonyl; phenylcarbonyl; (C1-C6)alkylcarbonyl; —(CH2)p—COOR′; or phenylsulphonyl group;and when X represents a carbon atomR3 represents a hydrogen atom; a group —NR5R6; —NHCOR7; —CONHR5; —COR7; —NHCONH2; —OH or —CH2OH,R4 represents in particular a hydrogen atom; an optionally substituted group —(CH2)p-phenyl; a group —(CH2)p-heteroaryl; or a group —(CH2)tNR7R8.Preparation process and therapeutic application.
REFERENCES:
patent: 5589476 (1996-12-01), Jegham et al.
patent: 6448271 (2002-09-01), Lubisch et al.
patent: 6548494 (2003-04-01), Webber et al.
patent: 2171579 (1996-09-01), None
patent: 0 732 334 (1986-09-01), None
patent: 0 646 583 (1995-04-01), None
patent: WO 00/32579 (2000-06-01), None
Emanuela Mazzon et al., “GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti- inflammatory effect in rat models of inflammation,”European Journal of Pharmacology415:85-94 (2001).
Andrew A. Pieper et al., “Poly (ADP-ribose) polymerase, nitric oxide and cell death,”Trends in Pharmaceutical Sciences20:171-181 (1999).
Csaba Szabó et al., “Role of poly(ADP-ribose) synthetase in inflammation and ischaemia- reperfusion,”Trends in Pharmaceutical Sciences19:287-298 (1998).
Derwent abstract for EP 0 646 583, dated Apr. 5, 1995.
Derwent abstract for EP 0 732 334, dated Sep. 18, 1886.
Derwent abstract for WO 00/32579, dated Jun. 8, 2000.
Barth Francis
Bichon Daniel
Bolkenius Frank
Dorsselaer Viviane Van
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Kifle Bruck
Sanofi-Synthelabo
LandOfFree
Benzimidazole derivatives, preparation and therapeutic use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives, preparation and therapeutic use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives, preparation and therapeutic use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3495327